跳至主要内容
临床试验/NCT05629299
NCT05629299尚未招募不适用

Pilot Study to Detect Monkey Pox Virus in Sperm: POXSPERM

University Hospital, Toulouse1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年11月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
MPXV genomic DNA

研究概览

简要总结

Given the current emerging epidemic of the MonkeyPox Virus (MPXV) and its route of transmission, the main objective of this pilot study is to characterize the presence of the MPXV in the semen of patients in the acute phase of infection and following this infection.

详细描述

Since May 2022, a total of 16 000 new cases of Monkey Pox Virus infection has been reported in 76 non-endemic countries. The WHO has declared this epidemic as a public health emergency. Principal routes of transmission are direct skin or mucosa contact or aerosol transmission. The current epidemic mainly affects men having sexual relations with others men and men reporting having recent sexual relations with new or multiple partners. We may wonder if there is a risk of transmission during an intercourse. Moreover, Monkey pox virus infection in human testicle has not been studied yet. Among viruses that infect human semen, some viruses can persist for several months or even years in the semen of cured men. In this context, we propose a research project about the pathophysiology of MPXV in the male genital tract by a clinical approach. Men with a diagnosis of MPXV infection confirmed by a positive PCR and who agreed to be included as volunteer will go to CECOS at Paule de Viguier Hospital, Purpan. Each patient will take a semen and urine sample, have a blood sample and a saliva sample, and a skin sample in case of a lesion; the earliest after the confirmation of the diagnosis of the infection (before the 7th day, the days will be noted) then on Day 15, Day 30, Day 60, Day 90 and Day 180.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • in the acute phase of MPXV infection and whose PCR reveals the viral genome in a skin sample or in any other sample.
  • able to travel to the laboratory for the samples
  • who gave his free and informed consent and having signed the consent
  • Patient affiliated to a social security scheme or equivalent

排除标准

  • Patient who has previously consulted for male infertility or who has previously performed an abnormal semen test (WHO standard)
  • Patient with ejaculation disorder or unable to collect semen or with abnormal semen volume (<1.5 mL).
  • Patient who presents serious clinical signs that do not allow him to travel to the investigation center.
  • Patient under a protection regime (including guardianship, curatorship or safeguard of justice)

结局指标

主要结局

MPXV genomic DNA

时间窗: Day 0

presence of MPXV DNA in the semen and others body fluids of infected patients in the acute phase and during the follow-up.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验